Indoco Remedies Ltd

Filing scope

• BRR for FY2025-26 filed; standalone basis; Regulation 34(2)(f); uploaded on company website.

Environmental metrics

• Renewable energy share reached 43.5% of total energy use.
• Total energy consumption ~36.41 million MJ; emission intensity 0.23 tCO2e per Lakh turnover (PPP 4.60).
• Water withdrawal 339,737 KL; down 16.7% year-on-year.
• Total waste 1,354.59 MT; waste intensity 0.0083 MT/Lakh turnover.
• EPR: 1,199 tons packaging introduced; credits to be procured by 30 Jun 2026.

GHG emissions and intensity

• GHG Scope1 12,378; Scope2 24,581; total 36,959 tCO2e; intensity 0.23 tCO2e per Lakh turnover (PPP 4.60).

ESG targets and governance

• 2030 ESG targets set; baseline FY2025-26; 3% reductions in freshwater, energy and Scope1+2 emissions.

Product safety and disclosures

• Voluntary product recalls: 3; not due to safety concerns; no data breaches.

Financial & operational highlights

• FY2025-26 standalone revenue ₹1,686 crore; total income ₹1,715.7 crore.
• Standalone EBITDA ₹157.16 crore; PAT ₹-5.66 crore; Basic EPS ₹-0.61.
• Final dividend ₹0.20 per share; AGM 17 Sep 2026.
• 10 manufacturing sites; sterile units 16 lakh.
• Formulation units 348 crore; APIs & Intermediates 358 MT.
• USFDA Patalganga facility: zero observations.
• EU GMP inspections at Goa and Baddi; LAGeSo approvals.
• Auditors' reports: unqualified opinions.
• Aditi Panandikar re-appointed MD for 2027-32; Vasudha V Kamat term to 2030.
• ESG: EcoVadis Bronze; CSR spend ₹242.59 lakh.

AGM Details

• Date/time/mode: 17 Sep 2026 at 10:30 IST, VC/OAVM.
• Record date: 10 Sep 2026.
• Book closure: 11 Sep to 17 Sep 2026 (inclusive).
• Remote e-voting window: 13 Sep 2026 09:00 to 16 Sep 2026 17:00; cut-off 10 Sep 2026.
• AGM venue: registered office; no physical venue due to VC/OAVM.

Resolutions Put to Vote (Ordinary)

• Adoption of standalone financial statements and reports.
• Adoption of consolidated financial statements and report of auditors.
• Final dividend per share Rs 0.20; subject to member approval.
• Re-appointment of Ms. Aditi Panandikar as Director (retiring by rotation).

Resolutions Put to Vote (Special)

• Re-appointment of Ms. Aditi Panandikar as Managing Director for five years.

AGM Details and Key Resolutions

• AGM date/time: 17 September 2026 at 10:30 IST; mode: VC/OAVM.
• Record date: 10 September 2026.
• Book closure: 11–17 September 2026.
• Ordinary: adopt standalone financial statements and Directors' reports.
• Ordinary: adopt consolidated financial statements.
• Ordinary: declare final dividend of Rs 0.20 per equity share.
• Ordinary: re-appoint Ms Aditi Panandikar as Director by rotation.
• Special: ratify cost auditors' remuneration for year ending 31 March 2027.
• Special: re-appoint Ms Aditi Panandikar as Managing Director for five years from 15 Feb 2027.
• Special: material related-party disclosures include intercompany loan to Warren Remedies Pvt Ltd converted to equity (Rs 10,779 lakh).

Dividend entitlement and key dates

• Record date is 10 September 2026 for entitlement to final dividend (₹0.20 per equity share).
• Book closure from 11 September 2026 to 17 September 2026 for dividend payment and AGM.
• Final dividend of ₹0.20 per equity share is subject to shareholders' approval at the AGM.
• Payment will be made within 30 days if approved.
• Cut-off date for remote e-voting and AGM: 10 September 2026.